DH (Definitive Healthcare) 5-Year RORE % : 16.40% (As of Mar. 2026)


DH Definitive Healthcare Corp DH
51 GF Score
Price $0.78
GF Value $4.44
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Definitive Healthcare 5-Year RORE %?

Definitive Healthcare DH -3.20% 51 5-Year RORE % is 16.40 as of Mar. 2026. GuruFocus rates DH with a GF Score™ of 51/100 and a GF Value™ of $4.44 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 509 Healthcare Providers & Services companies, Definitive Healthcare ranks better than 69.94% on this metric.

Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments. Definitive Healthcare's 5-Year RORE % for the quarter that ended in Mar. 2026 was 16.40%.

The industry rank for Definitive Healthcare's 5-Year RORE % or its related term are showing as below:

DH's 5-Year RORE % is ranked better than
69.94% of 509 companies
in the Healthcare Providers & Services industry
Industry Median: 2.84 vs DH: 16.40

Definitive Healthcare  (NAS:DH) 5-Year RORE % Explanation

Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.

There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 5-year period is chosen.

Be Aware

Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.


Definitive Healthcare 5-Year RORE % Related Terms


Definitive Healthcare 5-Year RORE % Historical Data

* Premium members only.

The historical data trend for Definitive Healthcare's 5-Year RORE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Definitive Healthcare 5-Year RORE % Chart

Definitive Healthcare Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
5-Year RORE %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 15.47

Definitive Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
5-Year RORE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 23.37 15.47 16.40

DH vs DRIO, CCLD, OPRX: 5-Year RORE % Comparison

For the Health Information Services subindustry, Definitive Healthcare's 5-Year RORE %, along with its competitors' market caps and 5-Year RORE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Definitive Healthcare 5-Year RORE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Definitive Healthcare's 5-Year RORE % distribution charts can be found below:

* The bar in red indicates where Definitive Healthcare's 5-Year RORE % falls into.


DH
51GF Score
Definitive Healthcare Corp DH
5-Year RORE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Definitive Healthcare 5-Year RORE % Calculation

Definitive Healthcare's 5-Year RORE % for the quarter that ended in Mar. 2026 is calculated as:

5-Year RORE %=( Most Recent EPS (Diluted)- First Period EPS (Diluted) )/( Cumulative EPS (Diluted) for 5-year -Cumulative Dividends per Share for 5-year )
=( -1.62--0.28 )/( -8.17-0 )
=-1.34/-8.17
=16.40 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of 5-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 5-year before.

Frequently Asked Questions Learn more about 5-Year RORE % →
What does a 5-Year RORE % of 16.40 mean?
Definitive Healthcare (DH) has a 5-Year RORE % of 16.40 as of Mar. 2026. 5-Year RORE % shows how much a company earns by reinvesting its retained earnings in 5-year. View historical data on Definitive Healthcare and its competitors. According to the industry distribution chart, Definitive Healthcare ranks #153 out of 509 companies in the Healthcare Providers & Services industry, placing it in the top 30.1%.
Is Definitive Healthcare's 5-Year RORE % too high?
Definitive Healthcare's current 5-Year RORE % is 16.40. The Healthcare Providers & Services industry median 5-Year RORE % is 2.84. Definitive Healthcare's value of 16.40 is 477.5% above this industry median. Based on the distribution chart, Definitive Healthcare ranks #153 out of 509 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Definitive Healthcare has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Definitive Healthcare's 5-Year RORE % compare to DRIO and CCLD?
According to the Healthcare Providers & Services industry distribution chart, Definitive Healthcare ranks #153 out of 509 companies for 5-Year RORE %. This puts Definitive Healthcare in the upper half of its industry. The industry median 5-Year RORE % is 2.84. Definitive Healthcare's value of 16.40 is 477.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year RORE % for a Healthcare Providers & Services company?
The median 5-Year RORE % among Healthcare Providers & Services companies is 2.84, based on 509 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year RORE % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Definitive Healthcare's current 5-Year RORE % of 16.40 is 477.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year RORE % mean?
A high 5-Year RORE % can signal that a stock is expensive relative to its fundamentals. 5-Year RORE % shows how much a company earns by reinvesting its retained earnings in 5-year. View historical data on Definitive Healthcare and its competitors. For the Healthcare Providers & Services industry, the median 5-Year RORE % is 2.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Definitive Healthcare's current 5-Year RORE % is 16.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Definitive Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Definitive Healthcare (DH) is currently considered Possible Value Trap. The stock's GF Value™ is $4.44, compared to a current price of $0.78 — trading 82.5% below its estimated fair value. The current 5-Year RORE % is 16.40 and 477.5% above the Healthcare Providers & Services industry median of 2.84. Definitive Healthcare's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year RORE % calculated?
5-Year RORE % is calculated from a company's financial statements. For Definitive Healthcare (DH), the current 5-Year RORE % is 16.40 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Definitive Healthcare (DH) Overvalued in 2026?

Based on GuruFocus' analysis, Definitive Healthcare stock appears to be undervalued. The current stock price of $0.78 is trading 82.5% below its estimated GF Value™ of $4.44. GuruFocus considers Definitive Healthcare to be Possible Value Trap.

Key valuation signals for DH:

  • 5-Year RORE %: 16.40
  • GF Value™: $4.44 vs. price of $0.78 (82.5% below fair value)
  • GF Score™: 51/100 with 4 warning signs
  • Industry Position: 477.5% above the Healthcare Providers & Services median (#153 of 509)

No single metric tells the full story. See the DH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Definitive Healthcare Business Description

Address 492 Old Connecticut Path, Suite 401, Framingham, MA, USA, 01701
Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.
51GF Score

Get the complete analysis for DH

5-Year RORE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.78
Price
$4.44
GF Value